Myadm - myeloid-associated differentiation marker

Predicted to be involved in several processes, including negative regulation of heterotypic cell-cell adhesion; negative regulation of macromolecule metabolic process; and negative regulation of protein kinase C signaling. Predicted to be located in cortical actin cytoskeleton; membrane raft; and ruffle. Predicted to be active in cell-cell junction and plasma membrane. Is expressed in several structures, including bone marrow; extraembryonic component; intestine smooth muscle circular layer; limb; and lung. Orthologous to human MYADM (myeloid associated differentiation marker). [provided by Alliance of Genome Resources, Apr 2022]